Johnny Gayton, MD
Ophthalmology · Warner Robins, GANPI 1144224627
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 23.9%. Among ophthalmology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 333 payments — averaging $65.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beaver-visitec International, Inc.$5K
- Alcon Research LLC$2K
- AbbVie$2K
- Alcon$2K
- Shire North American Group Inc$2K
- Bausch & Lomb Americas Inc.$2K
- plus $8K from 27 others
What the payments were for
- Consulting fees$7,65035%
- Speaking & faculty fees$3,62517%
- Travel & lodging$8454%
- Food & beverage$9,50944%
- Education$180%
- Gifts$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beaver-visitec International, Inc. | 9 | $5,182 |
| Alcon Research LLC | 1 | $2,450 |
| AbbVie(2 entities) | 63 | $1,776 |
| Alcon | 87 | $1,625 |
| Shire North American Group Inc | 3 | $1,532 |
| Bausch & Lomb Americas Inc. | 21 | $1,508 |
| Glaukos Corporation | 15 | $1,461 |
| Eyepoint US, Inc. | 4 | $1,261 |
| Neomedix Corporation | 1 | $750 |
| Kala Pharmaceuticals, Inc. | 21 | $739 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 19 | $648 |
| Johnson & Johnson Surgical Vision, Inc. | 9 | $295 |
| Carl Zeiss Meditec USA, Inc. | 4 | $288 |
| Sun Pharmaceutical Industries Inc. | 11 | $265 |
| NEW World Medical,inc. | 2 | $258 |
| Harrow Eye, LLC | 5 | $224 |
| Tarsus Pharmaceuticals, Inc. | 7 | $221 |
| Eyevance Pharmaceuticals LLC | 7 | $212 |
| Sight Sciences, Inc. | 16 | $179 |
| Novartis | 8 | $173 |
| Rxsight Inc | 4 | $113 |
| Amgen | 1 | $104 |
| Aerie Pharmaceuticals, Inc. | 1 | $91 |
| Carl Zeiss Meditec, Inc. | 1 | $65 |
| Oyster Point Pharma, Inc. | 3 | $48 |
| Thea Pharma Inc. | 2 | $44 |
| Dompe US, Inc. | 2 | $38 |
| Rayner Intraocular Lenses Limited | 1 | $34 |
| Akorn Operating Company LLC | 1 | $33 |
| Iridex Corporation | 1 | $30 |
| Omeros Corporation | 1 | $19 |
| Ocular Therapeutix, Inc. | 1 | $16 |
| Biotissue Holdings Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NGENUITY$2,450
- XIIDRA$1,633
- DEXYCU$1,200
- iStent inject Trabecular Micro-Bypass Stent System$1,000
- enVista Aspire IOL$959
- TENEO$959
- STELLARIS ELITE$959
- INVELTYS$500
- DURYSTA$358
- LUMIGAN$236
- Kahook Dual Blade$221
- Streamline Surgical System$221
- Ahmed Glaucoma Valve$221
- XEN$125
- TRYPTYR$125
- MIEBO$125
- XEN GLAUCOMA TREATMENT SYSTEM$122
- VEVYE$121
- COMBIGAN$114
- LOTEMAX$109
How this compares
$21,692 in reported general payments places this provider in the 90th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IlevroNepafenac | 413 | $155,851 |
| ProlensaBromfenac Sodium | 128 | $45,976 |
| LumiganBimatoprost | 83 | $38,405 |
| RestasisCyclosporine | 25 | $34,105 |
| Prednisolone Acetate | 845 | $31,919 |
| RhopressaNetarsudil Mesylate | 52 | $24,217 |
| Bromfenac Sodium | 171 | $19,674 |
| CombiganBrimonidine Tartrate/Timolol | 44 | $13,259 |
| VyzultaLatanoprostene Bunod | 23 | $8,509 |
| RocklatanNetarsudil Mesylat/Latanoprost | 16 | $7,923 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 35 | $6,900 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 29 | $5,625 |
| Brimonidine Tartrate | 78 | $4,620 |
| Cyclosporine | 19 | $4,383 |
| Alphagan PBrimonidine Tartrate | 20 | $4,357 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisIlevro | $173 | $155,851413 claims |
| AbbVieLumigan, Restasis, Combigan, Alphagan P | $1,776 | $90,126172 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Loteprednol Etabonate | $648 | $48,126140 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $91 | $32,14068 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $1,508 | $8,50923 claims |
| AlconSimbrinza | $1,625 | $5,62529 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 481 ophthalmology providers in Georgia.
Other ophthalmology in Warner Robins
- Gagan SawhneyAtlanta$582K
- Lawrence WoodardAtlanta$578K
- Stephanie VanderveldtAtlanta$384K
- Steven YehAtlanta$289K
- Jack ChapmanGainesville$244K
- Gregory LeeCumming$214K
- Puneet PandaMarietta$185K
- Jeffrey TranSuwanee$150K
- Evan SchoenbergAtlanta$130K
- Niraj DesaiCumming$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.